PD Dr. Marlen Haderlein

Medizinische Fakultät Department of Radiation Oncology

Regulatory T cells and cytotoxic T cells close to the epithelial–stromal interface are associated with a favorable prognosis (2020) Rudolf J, Büttner-Herold M, Erlenbach-Wuensch K, Posselt R, Jeßberger J, Haderlein M, Hecht M, et al. Journal article Classification of three prognostically different groups of head and neck cancer patients based on their metabolic response to induction chemotherapy (IC-1) (2020) Semrau S, Schmidt D, Hecht M, Haderlein M, Kitzsteiner C, Müller S, Traxdorf M, et al. Journal article Is in vivo and ex vivo irradiation equally reliable for individual Radiosensitivity testing by three colour fluorescence in situ hybridization? (2019) Mayo T, Haderlein M, Schuster B, Wiesmueller A, Hummel C, Bachl M, Schmidt M, et al. Journal article Single-cycle induction chemotherapy before chemoradiotherapy or surgery in functionally inoperable head and neck squamous cell carcinoma: 10-year results (2019) Breheret M, Lubgan D, Haderlein M, Hecht M, Traxdorf M, Schmidt D, Müller SK, et al. Journal article CD8+and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck Cancer (2019) Echarti A, Hecht M, Büttner-Herold M, Haderlein M, Hartmann A, Fietkau R, Distel L Journal article Complete Remission with consecutive Pneumonitis in metastatic Bronchogenic Carcinoma after combination of Radiotherapy and Nivolumab - Immunological Correlate in peripheral Blood (2019) Hecht M, Donaubauer AJ, Becker I, Rutzner S, Lubgan D, Lettmaier S, Haderlein M, et al. Conference contribution Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? (2019) Onbasi Y, Lettmaier S, Hecht M, Semrau S, Iro H, Kesting MR, Fietkau R, Haderlein M Journal article Salivary gland carcinoma (SGC) with perineural spread and/or positive resection margin - High locoregional control rates after photon (chemo) radiotherapy - Experience from a monocentric analysis (2019) Haderlein M, Scherl C, Semrau S, Lettmaier S, Hecht M, Putz F, Iro H, et al. Journal article Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2) (2019) Merten R, Ott O, Haderlein M, Bertz S, Hartmann A, Wullich B, Keck B, et al. Journal article Outcome and management of rare high-grade “salivary” adenocarcinoma: the important role of adjuvant (chemo)radiotherapy (2019) Scherl C, Haderlein M, Agaimy A, Mantsopoulos K, Koch M, Traxdorf M, Fietkau R, et al. Journal article